Literature DB >> 23589609

Regulator of calcineurin 1 suppresses inflammation during respiratory tract infections.

Robert D Junkins1, Adam J MacNeil, Zhengli Wu, Craig McCormick, Tong-Jun Lin.   

Abstract

Respiratory tract infection with Pseudomonas aeruginosa is a common cause of hospitalization in immune-compromised individuals. However, the molecular mechanisms involved in the immune response to P. aeruginosa lung infection remain incompletely defined. In this study, we demonstrate that the regulator of calcineurin 1 (RCAN1) is a central negative regulator of inflammation in a mouse model of acute bacterial pneumonia using the opportunistic bacterial pathogen P. aeruginosa. RCAN1-deficient mice display greatly increased mortality following P. aeruginosa lung infection despite enhanced neutrophil recruitment and bacterial clearance. This mortality is associated with higher systemic levels of proinflammatory cytokines in RCAN1-deficient animals. These aberrant inflammatory responses coincide with increased transcriptional activity of proinflammatory RCAN1-target proteins NFAT and NF-κB. In addition, we reveal a novel regulatory role for RCAN1 in the ERK/STAT3 pathway both in vitro and in vivo, suggesting that aberrant STAT3 activity may significantly contribute to delayed resolution of inflammatory responses in our model. Together, these findings demonstrate that RCAN1 is a potent negative regulator of inflammation during respiratory tract infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589609     DOI: 10.4049/jimmunol.1203196

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Regulator of Calcineurin 1 helps coordinate whole-body metabolism and thermogenesis.

Authors:  David Rotter; Heshan Peiris; D Bennett Grinsfelder; Alyce M Martin; Jana Burchfield; Valentina Parra; Christi Hull; Cyndi R Morales; Claire F Jessup; Dusan Matusica; Brian W Parks; Aldons J Lusis; Ngoc Uyen Nhi Nguyen; Misook Oh; Israel Iyoke; Tanvi Jakkampudi; D Randy McMillan; Hesham A Sadek; Matthew J Watt; Rana K Gupta; Melanie A Pritchard; Damien J Keating; Beverly A Rothermel
Journal:  EMBO Rep       Date:  2018-11-02       Impact factor: 8.807

2.  Regulator of Calcineurin 1 in Periodontal Disease.

Authors:  Ulrike Peters; Eleni Solominidou; Yüksel Korkmaz; Stefan Rüttermann; Astrid Klocke; Thomas Frank Flemmig; Thomas Beikler
Journal:  Mediators Inflamm       Date:  2016-06-15       Impact factor: 4.711

3.  Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.

Authors:  Zheng Pang; Robert D Junkins; Renee Raudonis; Adam J MacNeil; Craig McCormick; Zhenyu Cheng; Tong-Jun Lin
Journal:  PLoS One       Date:  2018-05-25       Impact factor: 3.240

4.  PTP1B negatively regulates nitric oxide-mediated Pseudomonas aeruginosa killing by neutrophils.

Authors:  Lei Yue; Min Yan; Michel L Tremblay; Tong-Jun Lin; Hua Li; Ting Yang; Xia Song; Tianhong Xie; Zhongping Xie
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

5.  The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice.

Authors:  C Liu; L Zheng; H Wang; X Ran; H Liu; X Sun
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

6.  A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages.

Authors:  Camille Danne; Grigory Ryzhakov; Maria Martínez-López; Nicholas Edward Ilott; Fanny Franchini; Fiona Cuskin; Elisabeth C Lowe; Samuel J Bullers; J Simon C Arthur; Fiona Powrie
Journal:  Cell Host Microbe       Date:  2017-12-13       Impact factor: 21.023

7.  IL-17RC is critically required to maintain baseline A20 production to repress JNK isoform-dependent tumor-specific proliferation.

Authors:  Chi Yan; Yang Lei; Tong-Jun Lin; David W Hoskin; Averil Ma; Jun Wang
Journal:  Oncotarget       Date:  2017-06-27

8.  Endothelial Regulator of Calcineurin 1 Promotes Barrier Integrity and Modulates Histamine-Induced Barrier Dysfunction in Anaphylaxis.

Authors:  Constanza Ballesteros-Martinez; Nerea Mendez-Barbero; Alma Montalvo-Yuste; Bettina M Jensen; Aída Gomez-Cardenosa; Lotte Klitfod; María Garrido-Arandia; Gloria Alvarez-Llamas; Carlos Pastor-Vargas; Fernando Vivanco; Lene Heise Garvey; Javier Cuesta-Herranz; Lars K Poulsen; Vanesa Esteban
Journal:  Front Immunol       Date:  2017-10-20       Impact factor: 7.561

9.  Anti-inflammatory properties of uvaol on DSS-induced colitis and LPS-stimulated macrophages.

Authors:  Shi-Yun Du; Hai-Feng Huang; Xian-Qian Li; Li-Xiang Zhai; Qin-Chang Zhu; Kai Zheng; Xun Song; Chen-Shu Xu; Chen-Yang Li; Ying Li; Zhen-Dan He; Hai-Tao Xiao
Journal:  Chin Med       Date:  2020-05-07       Impact factor: 5.455

10.  CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection.

Authors:  Lei Yue; Zheng Pang; Hua Li; Ting Yang; Lei Guo; Longding Liu; Junjie Mei; Xia Song; Tianhong Xie; Ye Zhang; Xin He; Tong-Jun Lin; Zhongping Xie
Journal:  PLoS One       Date:  2018-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.